All In MedTech

FDA Clearance Tracker · P000027-S006

ELECSYS FREE PSA TEST SYSTEM ON COBAS E 601 IMMUNOASSAY ANALYZER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 17, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 17, 2008

Approved

Time to decision

203 days

Received Mar 28, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000027-S006
Device name
ELECSYS FREE PSA TEST SYSTEM ON COBAS E 601 IMMUNOASSAY ANALYZER
Applicant location
Indianapolis, IN
Received
Mar 28, 2008
Decided
Oct 17, 2008
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000027

Device type

Device class
Class III

Every decision under product code MTG

FDA's approval statement

As written in FDA's record.

APPROVAL FOR EXTENSION OF THE ELECSYS FREE PSA SYSTEM ONTO UPDATED MODEL OF THE MODULAR ANALYTICS E170 ANALYZER, KNOWN AS THE COBAS E 601 ANALYZER.

Source documents

Other decisions for Roche Diagnostics Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.